فضلا اضغط بالاسفل
يستعمل دواء زينثا 250وحدة بودر فيال xyntha 250 i.u. lyophilized powder vial blood-coagulation factor blood-coagulation factor
xyntha� antihemophilic factor (recombinant) is indicated in adults and children with hemophilia a (congenital factor viii deficiency or classic hemophilia) for control and prevention of bleeding episodes and for perioperative management. - -when blood vessels are cut or damaged the loss of blood from the system must be stopped before shock and possible death occur. this is accomplished by solidification of the blood a process called coagulation or clotting. - -a blood clot consists of -a plug of platelets enmeshed in a -network of insoluble fibrin molecules. -the extrinsic pathway - -damaged cells display a surface protein called tissue factor (tf) -tissue factor binds to activated factor 7. -the tf-7 heterodimer is a protease with two substrates: -factor 9 and -factor 10 -the intrinsic pathway
تركيبة دواءزينثا 250وحدة بودر فيال xyntha 250 i.u. lyophilized powder vial
يتركب هذا الدواء من :blood-coagulation factor viii
الشركة المنتجة لدواءزينثا 250وحدة بودر فيال xyntha 250 i.u. lyophilized powder vial
هذا الدواء من انتاج شركة wyeth pharmaceuticals company > pfizer
جرعة دواءزينثا 250وحدة بودر فيال
Welcome to Dlildwa, specifically the page of xyntha 250 i.u. lyophilized powder vial.
تم استعراض بدائل هذا الدواء 245 مرة